<DOC>
	<DOCNO>NCT01689389</DOCNO>
	<brief_summary>The aim study describe patient characteristic ( demographic clinical ) pattern use Quetiapine XR patient receive drug first time real-life practice regardless final diagnosis .</brief_summary>
	<brief_title>Description Use Quetiapine Extended Release ( XR ) Real-life Practice France . An Observational Study</brief_title>
	<detailed_description>Description use Quetiapine Extended Release ( XR ) real-life practice France</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>New patient treat Xeroquel XR Patients age 18 year Diagnosis bipolar disorder schizophrenia accord DSMIV criterion Patient include therapeutic trial ( HurietSerusclat Act ) Patient refuse participate study Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Bipolar episode</keyword>
	<keyword>France</keyword>
	<keyword>Xeroquel</keyword>
	<keyword>Real-life</keyword>
</DOC>